INF2 and focal segmental glomerulosclerosis: In 2011, Boyer et al. identified that INF2 mutations were a major cause of CMT associated with focal segmental glomerulosclerosis, accounting for 12 of 16 cases in their cohort (Boyer, Nevo, et al., 2011).